Advertisement Pharmaceutical Business review - Page 5216 of 5291 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 24, 2026

Basecamp Research secures $140m for AI-driven therapies

UK-based Basecamp Research has secured $140m in a Series C funding round to train a new generation of its EDEN biological foundation models and advance AI-designed therapies towards clinical development.

Continue
Basecamp’s initial therapeutic focus is in vivo cell therapy, which involves reprogramming the cells of a patient inside the body. Credit: Basecamp Research.
September 24, 2026

Genialis and Inventia to enhance pancreatic cancer treatment testing

RASTRUM creates 3D pancreatic cancer models in which tumour and stromal components can be controlled and altered independently. Credit: sasirin pamai / Shutterstock.com.
September 23, 2026

BoomRay and Novartis Pharma sign $900m deal for radioligand therapy

The partnership brings together BoomRay’s development experience in RLTs and Novartis’s global presence in the field. Credit: Michael Derrer Fuchs / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Boehringer and Envisagenics to develop precision cancer therapies
  2. Made Scientific acquires cell therapy facility in Pennsylvania, US
  3. EC approves Menarini and NewAmsterdam’s obicetrapib therapies
  4. Telix to acquire ITM in deal worth up to $2.35bn
  5. Sandoz and mAbxience agree on emicizumab biosimilar partnership

PRESS RELEASES

Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Gerresheimer Reports Slight Revenue Growth in Q1 2026 and a Strong Focus on Free Cash Flow
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with cartriQ® BioPure
Pharmaceutical Business Review
SCHOTT Pharma and Nemera Deliver Verified Pen Injector Platform with Sterile Cartridge System
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary
SCHOTT Pharma Invests in Sterile Cartridge Production in Hungary

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography